Clinical Trials in Las Condes, Arica Y Parinacota

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

NCT ID: NCT03930953

This clinical trial is studying a new treatment called CC-99282, both on its own and combined with other medications, for people with relapsed or refractory non-Hodgkin lymphoma (NHL). This means i...